Welcome to our dedicated page for BIO-key International news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on BIO-key International stock.
BIO-key International, Inc. reports developments in identity and access management software, biometric authentication technology, and related security hardware. The company’s updates center on cloud-hosted and on-premise PortalGuard IAM, biometric-centric multi-factor authentication, Passkey:YOU, and devices such as Pocket 10 Finger Scanners and Mobile POS Pro. Customer news includes software license renewals, public-sector channel partnerships, defense deployments, and retail-bank biometric identification programs.
Financial and corporate updates also cover operating results, revenue contributions from services, license fees, and hardware, Nasdaq listing compliance, periodic-report timing, and share-structure actions such as the company’s 1-for-10 reverse stock split.
BIO-key (BKYI) received Full Certification from the FIDO Alliance for its Passkey:YOU™ authenticator, confirming compliance with the FIDO2/WebAuthn/Passkey standard for phishing-resistant, passwordless sign-in.
Passkey:YOU lets employees authenticate with a fingerprint, palm, face, or existing door-access badge, without requiring smartphones or separate hardware tokens. A single enrollment works across passkey-enabled services, including Microsoft Entra ID, Okta, Ping, Duo, BIO-key PortalGuard®, and supported websites, with no separate integrations. The product is centrally managed to give enterprises visibility and control over where credentials are used, and uses BIO-key’s Identity-Bound Biometrics, NIST-tested fingerprint platform, and MobileAuth app to support regulated, shared-workstation, and phone-restricted environments.
BIO-key (NASDAQ: BKYI) announced that CEO Michael DePasquale will be available for virtual investor meetings during H.C. Wainwright’s 28th Annual Global Investment Conference on September 15 and 17, 2026. BIO-key’s on-demand presentation will be accessible to registered attendees starting September 11, 2026 at 7:00 a.m. ET via the conference website on the Technology, Media & Telecommunications Growth Track (Track 2).
BIO-key (Nasdaq: BKYI) reported Q2 2026 revenue of $1.92M, up 13% year over year, driven by a 53% increase in license fees to $1.23M, while hardware revenue fell 19% and services declined 28%.
Gross margin rose to 87% from 73%, lifting gross profit to $1.67M. Operating expenses fell 5% to $2.20M, improving the Q2 net loss by 51% to $(577K). For 1H 2026, revenue grew 23% to $4.07M and net loss narrowed 59% to $(782K). A large, fully-reserved hardware order of about $0.8M was delayed from Q2 and is now expected in 2H 2026.
BIO-key completed a 1-for-10 reverse stock split in Q2 and regained Nasdaq listing compliance in July. As of June 30, 2026, the company had $1.4M in cash, then subsequently raised approximately $2.5M via warrant exercises, increasing cash to over $4.5M and reducing a 2025 note balance by $350K.
BIO-key International (Nasdaq: BKYI) entered into a warrant inducement agreement with an existing institutional investor covering warrants issued on October 28, 2025. The investor agreed to exercise warrants for 618,334 shares of common stock at a reduced exercise price of $4.06 per share, subject to beneficial ownership limits, generating expected gross proceeds of about $2.5 million before fees.
In consideration, BIO-key will issue the investor 1,236,668 new unregistered warrants with a $4.06 exercise price, exercisable for five years starting on stockholder approval under Nasdaq rules. BIO-key plans to file an SEC registration statement for resale of shares issuable upon exercise of the new warrants.
BIO-key International (Nasdaq: BKYI) and its strategic partner Visualforma have been awarded a new contract to enhance digital identity security for a Portuguese national security agency, extending their work from municipalities and public administration into one of Portugal’s most security-sensitive environments.
The deployment will use BIO-key’s PortalGuard IAM platform, WEB-key biometric authentication, Identity-Bound Biometrics (IBB), PIN:You PIN-based authentication, and EcoID III FBI PIV-certified fingerprint scanners to secure access to administrative systems, privileged accounts, and critical applications while meeting strict operational and cybersecurity requirements.
BIO-key (NASDAQ: BKYI) will host its Q2 2026 investor call and webcast on Friday, August 14th at 10 a.m. ET, led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch. Investors can join via U.S. dial-in 1-877-418-5460, international 1-412-717-9594, or a live webcast with replay available for three months.
BIO-key (Nasdaq: BKYI) announced a strategic partnership with Maktabi Tech, a regional technology firm focused on digital transformation and cybersecurity for the education sector in Saudi Arabia, Jordan, and the UAE. The collaboration will deliver BIO-key’s PortalGuard IAM platform, including Multi-Factor Authentication, Single Sign-On, passwordless authentication, and Identity-Bound Biometrics, to educational institutions across Saudi Arabia.
The partnership leverages Maktabi Tech’s established relationships and senior cybersecurity specialists to support identity modernization for schools, universities, and educational organizations. According to BIO-key, the agreement expands its presence in Saudi Arabia and aligns with the Kingdom’s Vision 2030 digital transformation and cybersecurity initiatives in education.
BIO-key (Nasdaq: BKYI) announced that the Central Bank of Jordan (CBJ) has selected the company for a national biometric authentication initiative across Jordan’s financial sector, which serves about 11.6 million people. The project aims to shift end-client authentication toward a biometric-first model, reducing reliance on passwords, tokens and other legacy methods.
The CBJ is using BIO-key’s PortalGuard and WEB-key technologies to enable secure biometric authentication across digital and financial environments. BIO-key’s past contribution to a biometric banking deployment serving over 30 million customers and 850+ branches was highlighted. The scope, implementation framework and timeline for the Jordan initiative are still being developed between CBJ and BIO-key.
BIO-key (Nasdaq: BKYI) announced that trading of its common stock will resume on the Nasdaq Capital Market at the market open on Wednesday, July 8, 2026. A Nasdaq Hearings Panel determined the company has regained compliance with continued listing standards, including minimum bid price and SEC filing requirements. BIO-key will be under a Discretionary Panel Monitor until July 6, 2027. Management highlights a growing base of recurring revenue, expanding interest in its biometric cybersecurity solutions, a solid financial position, and a streamlined cost structure, and expects significantly improved business results in 2026.
BIO-key (OTCQB: BKYI) will showcase its biometric-powered, passwordless identity and access management solutions at an invitation-only banking cybersecurity workshop in Amman, Jordan, on July 6. The Association of Banks in Jordan is hosting over 25 financial institutions, including C-level executives.
Sessions highlight BIO-key’s Identity-Bound Biometrics and PortalGuard IAM for secure, frictionless authentication, improved user experience, operational efficiency, regulatory compliance support, and cyber threat mitigation for regional banks undergoing digital transformation.